Literature DB >> 27884318

N-acetylcysteine ameliorates liver injury in a rat model of intestinal ischemia reperfusion.

Konstantinos Kalimeris1, Panagiotis Briassoulis2, Agathi Ntzouvani3, Tzortzis Nomikos3, Kleio Papaparaskeva4, Aikaterini Politi5, Chrysanthi Batistaki2, Georgia Kostopanagiotou2.   

Abstract

BACKGROUND: N-acetylcysteine (NAC) is an antioxidant with direct and indirect antioxidant actions used in the clinical setting. Oxidative stress is known to play a pivotal role in the intestinal ischemia reperfusion (IIR). Therefore, we studied the effect of different pretreatment regimens with NAC on the IIR injury in rats.
MATERIALS AND METHODS: Thirty-five male Wistar rats were randomly assigned to five groups. In group sham, only laparotomy was performed. Group control underwent IIR without NAC. In the other groups, NAC was administered intraperitoneally with different regimens: 150 mg/kg before ischemia (NAC 150), 300 mg/kg before ischemia (NAC 300), and 150 mg/kg before ischemia plus 150 mg/kg 5 min before reperfusion (NAC 150 + 150). Measurements in tissues and blood were conducted at 4 h of reperfusion following exsanguination.
RESULTS: Histological score of the liver was significantly improved in NAC 300 compared with control (1.7 ± 0.5 versus 2.9 ± 1.1, respectively, P = 0.05). In addition, NAC treatment significantly reduced liver transaminases in all groups of treatment, mostly in group NAC 300. Plasma malondialdehyde levels were lower with NAC treatment, although not statistically significant. Lung glutathione peroxidase was significantly increased in group NAC 300 (P = 0.04), while the other oxidation biomarkers showed no significant differences.
CONCLUSIONS: NAC exerts a significant protective role in liver injury following IIR, which seems to be independent of an intestinal protective effect. Additional administration of NAC before reperfusion was of no further benefit. The most effective regimen among the compared regimens was that of 300 mg/kg before ischemia. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intestinal ischemia reperfusion; Liver injury; N-acetylcysteine; Oxidative stress; Rat model

Mesh:

Substances:

Year:  2016        PMID: 27884318     DOI: 10.1016/j.jss.2016.08.049

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Identification of novel N-acetylcysteine derivatives for the treatment of hepatocellular injury.

Authors:  Shourong Liu; Yanmei Zhao; Ruoyu He; Limin Kong; Jianjun Xi; Jingjing Sun; Yidan Shao; Xuwang Pan; Jiankang Zhang; Rangxiao Zhuang
Journal:  Medchemcomm       Date:  2017-10-19       Impact factor: 3.597

2.  Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway.

Authors:  Iman O Sherif; Nora H Al-Shaalan
Journal:  Oxid Med Cell Longev       Date:  2018-10-14       Impact factor: 6.543

Review 3.  Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies.

Authors:  Ricardo O S Soares; Daniele M Losada; Maria C Jordani; Paulo Évora; Orlando Castro-E-Silva
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

Review 4.  Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine.

Authors:  Tingting Shi; Li Wu; Wenjun Ma; Liping Ju; Minghui Bai; Xiaowei Chen; Shourong Liu; Xingxin Yang; Junping Shi
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-04       Impact factor: 2.629

Review 5.  Shaping of Hepatic Ischemia/Reperfusion Events: The Crucial Role of Mitochondria.

Authors:  João S Teodoro; Rui T Da Silva; Ivo F Machado; Arnau Panisello-Roselló; Joan Roselló-Catafau; Anabela P Rolo; Carlos M Palmeira
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

6.  Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats.

Authors:  Huiting Li; Yitong Pan; Hongjuan Wu; Shuna Yu; Jianxin Wang; Jie Zheng; Can Wang; Jianguo Li; Jiying Jiang
Journal:  PeerJ       Date:  2020-04-09       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.